Fe3O4/salicylic acid nanoparticles versatility in magnetic mediated vascular nanoblockage
Source abstract
Abstract
An aqueous dispersion of Fe3O4/salicylic acid magnetic nanoparticles (SaMNPs) was synthesized by a modified Massart method, characterized by Inductively Coupled Plasma–Optic Emission Spectrometry (ICP-OES), High-Resolution Transmission Electron Microscopy (HRTEM) and Dynamic Light Scattering (DLS) methods, and tested on the chick chorioallantoic membrane (CAM) model to evaluate biocompatibility, biodistribution, intravascular time persistence, and ability to be magnetically target driven in order to block the blood supply into a tumor xenograft. ICP-OES, DLS, and HRTEM SaMNPs sample analyses showed a 0.356 mg/mL Fe concentration, a good stability in water (average Zeta potential of 39.3 mV), a hydrodynamic diameter around 52 nm and a core diameter in the 7–15 nm range for the Fe3O4 nanoparticles. In vivo CAM assay showed that SaMNPs were biocompatible with the chick embryo, were fixed almost completely by the liver, had no embolic potential, and a threshold-dose-dependent intravascular magnetic targeting time. Study on the CAM tumor model showed that SaMNPs could be used for long-term magnetically mediated nanoblocking of the capillary networks and 70-µm smaller arterioles.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Micro and Nano Robotics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Ankamwar B, Lai TC, Huang JH, Liu RS, Hsiao M, Chen CH et al (2010) Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 21:75102. doi: 10.1088/0957-4484/21/7/07510210.1088/0957-4484/21/7/075102 ↗
2. Barry SE (2008) Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperther 24:451–46610.1080/02656730802093679 ↗
3. Bartneck M, Keul HA, Zwadlo-Klarwasser G, Jr Groll (2009) Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett 10:59–6310.1021/nl902830x ↗
4. Baxter GJ, Lawrence JR, Graham AB, Wiles D, Paterson JR (2002) Identification and determination of salicylic acid and salicyluric acid in urine of people not taking salicylate drugs. Ann Clin Biochem 39:50–5510.1258/0004563021901739 ↗
5. Buteică AS, Meşină M, Mîndrilă B, Mîndrilă I (2014) In vivo models combination for B16 murine melanoma study. Rom J Funct Clin, Macro–Microsc Anat Anthropol 13:143–147
6. Chen D, Tang Q, Li X, Zhou X, Zang J, Xue W et al (2012) Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells. Int J Nanomed 7:4973–4982. doi: 10.2147/IJN.s3514010.2147/IJN.S35140 ↗
7. Chouly C, Pouliquen D, Lucet I, Jeune J, Jallet P (1996) Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 13:245–25510.3109/02652049609026013 ↗
8. Deryugina EI, Quigley JP (2008) Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol 130:1119–113010.1007/s00418-008-0536-2 ↗
9. Gallo J, Long NJ, Aboagye EO (2013) Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. Chem Soc Rev 42:7816–783310.1039/c3cs60149h ↗
10. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomed (Lond) 2:23–3910.2217/17435889.2.1.23 ↗
11. Kobayashi T (2011) Cancer hyperthermia using magnetic nanoparticles. Biotechnol J 6:1342–1347. doi: 10.1002/biot.20110004510.1002/biot.201100045 ↗
12. Kue CS, Tan KY, Lam ML, Lee HB (2015) Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp Anim 64:129–138. doi: 10.1538/expanim.14-005910.1538/expanim.14-0059 ↗
13. Lee EA, Yim H, Heo J, Kim H, Jung G, Hwang NS (2014) Application of magnetic nanoparticle for controlled tissue assembly and tissue engineering. Arch Pharm Res 37:120–12810.1007/s12272-013-0303-3 ↗
14. Liu J, Flores GA, Sheng R (2001) In-vitro investigation of blood embolization in cancer treatment using magnetorheological fluids. J Magn Magn Mater 225:209–21710.1016/S0304-8853(00)01260-9 ↗
15. Mihaiescu DE, Buteică AS, Neamţu J, Istrati D, Mîndrilă I (2013) Fe3O4/salicylic acid nanoparticles behavior on chick CAM vasculature. J Nanopart Res 15:1–10. doi: 10.1007/s11051-031-1857-110.1007/s11051-013-1857-1 ↗
16. Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S (2012) Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PLoS ONE. doi: 10.1371/journal.pone.0048208
17. Peng XH, Qian X, Mao H, Wang AY (2008) Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed 3:311–321
18. Pisanic TR II, Blackwell JD, Shubayev VI, Fiñones RR, Jin S (2007) Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28:2572–258110.1016/j.biomaterials.2007.01.043 ↗
19. Ribatti D (2014) The chick embryo chorioallantoic membrane as a model for tumor biology. Exp Cell Res 328:314–32410.1016/j.yexcr.2014.06.010 ↗
20. Satchell SC, Braet F (2009) Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Ren Psysiol 296:947–95610.1152/ajprenal.90601.2008 ↗
21. Schlachter EK, Widmer HR, Bregy A, Lönnfors-Weitzel T, Vajtai I, Corazza N et al (2011) Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int J Nanomed 6:1793–1800. doi: 10.2147/IJN.S23638
22. Shubayev VI, Pisanic TR II, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467–47710.1016/j.addr.2009.03.007 ↗
23. Singh SP, Rahman M, Murty U, Mahboob M, Grover P (2013) Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol Appl Pharm 266:56–6610.1016/j.taap.2012.10.016 ↗
24. Smolkova IS, Kazantseva NE, Makoveckaya KN, Smolka P, Saha P, Granov AM (2015) Maghemite based silicone composite for arterial embolization hyperthermia. Mater Sci Eng, C 48:632–641. doi: 10.1016/j.msec.2014.12.04610.1016/j.msec.2014.12.046 ↗
25. Vargas A, Zeisser-Labouèbe M, Lange N, Gurny R, Delie F (2007) The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev 59:1162–117610.1016/j.addr.2007.04.019 ↗
26. Varna M, Ratajczak P, Ferreira I, Leboeuf C, Bousquet G, Janin A (2012) In vivo distribution of inorganic nanoparticles in preclinical models. J Biomater Nanobiotechnol 3:269–279. doi: 10.4236/jbnb.2012.32203310.4236/jbnb.2012.322033 ↗
27. Villanueva A, Canete M, Roca AG, Calero M, Veintemillas-Verdaguer S, Serna CJ et al (2009) The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 20:11510310.1088/0957-4484/20/11/115103 ↗
28. Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62:1064–107910.1016/j.addr.2010.07.009 ↗
29. Ying E, Hwang HM (2010) In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 408:4475–448110.1016/j.scitotenv.2010.07.025 ↗